HercepTest
Agilent Technologies Singapore (International) Pte , Ltd. · Decision date Sep 21, 2026
What did the FDA decide?
This record documents a 30-Day Notice supplement to PMA P980018, submitted by Agilent Technologies Singapore (International) Pte, Ltd. The reported statement describes approval for a supplier's change to the manufacturing site for a device component. The associated reason code is Process Change - Manufacturer/Sterilizer/Packager/Supplier. The device category is listed as SYSTEM, TEST, HER-2/NEU, IHC, under product code MVC, specialty Pathology.
The supplemental identifier P980018/S027 ties the notice to original PMA P980018, so a manufacturing-site change is not an approval of the whole HercepTest system. The record does not name the component, the prior or new manufacturing site, or any validation data, and it does not establish safety or clinical effectiveness. The stated purpose is a supplier manufacturing-site change; the source gives no further technical detail.
Researchers should read this as a descriptive database entry limited to that scope, without inferring new indications, performance changes, or trial data.
FDA approval order statement
approval for a supplier's change to the manufacturing sight for a device component
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Pathology
- Decision date
- Sep 21, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P980018/S027
- Regulatory pathway
- PMA supplement
- Product code
- MVC
- Decision code
- OK30
- Decision date
- Sep 21, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: SYSTEM, TEST, HER-2/NEU, IHC.
- Product code
- MVC
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P980018. Subsequent supplements may change the device or its indications.
FDA decision timeline
P980018 · Original PMA
DAKO HERCEPTEST
P980018/S027 received
Application receipt date recorded by FDA.
P980018/S027 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P980018. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P980018
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
DAKO HERCEPTESTP980018 | Agilent Technologies Singapore (International) Pte , Ltd. | PMA approval | Sep 25, 1998 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Agilent Technologies Singapore (International) Pte , Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- # 1 Yishun Ave. 7, Singapore, 768923
Sources and methodology
- Original FDA record: P980018/S027
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records